Effect of phospholipidosis on the cellular pharmacokinetics of chloroquine

Journal of Pharmacology and Experimental Therapeutics

Volumn 336, Issue 3, 2011, Pages 661-671

  Zheng, Nan ^a   Zhang, Xinyuan ^b   Rosania, Gus R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN A1; CHLOROQUINE; SUCROSE;

ACTIVE TRANSPORT; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL STRAIN; CONFOCAL MICROSCOPY; CYTOPLASM VESICLE; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG UPTAKE; KIDNEY DISTAL TUBULE; LIPIDOSIS; NONHUMAN; PASSIVE TRANSPORT; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CELL MEMBRANE; CELL SIZE; CHLOROQUINE; DOGS; LIPIDOSES; PHOSPHOLIPIDS; TISSUE DISTRIBUTION;

EID: 79951962784     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.175679     Document Type: Article

References (40)

1. Bawolak MT, Morissette G, and Marceau F (2010) Vacuolar ATPase-mediated sequestration of local anesthetics in swollen macroautophagosomes. Can J Anaesth 57:230-239.
2. Bergqvist Y, Hed C, Funding L, and Suther A (1985) Determination of chloroquine and its metabolites in urine: a field method based on ion-pair extraction. Bull World Health Organ 63:893-898. (Pubitemid 16148541)
3. de Duve C, de Barsy T, Poole B, Trouet A, Tulkens P, and Van Hoof F (1974) Commentary. Lysosomotropic agents. Biochem Pharmacol 23:2495-2531.
4. Djordevic B, Lange CS, and Rotman M (1992) Potentiation of radiation lethality in mouse melanoma cells by mild hyperthermia and chloroquine. Melanoma Res 2:321-326. (Pubitemid 23084478)
5. Ducharme J and Farinotti R (1996) Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements. Clin Pharmacokinet 31:257-274.
6. Duvvuri M and Krise JP (2005) A novel assay reveals that weakly basic model compounds concentrate in lysosomes to an extent greater than pH-partitioning theory would predict. Mol Pharm 2:440-448. (Pubitemid 43016385)
7. Engel K and Wang J (2005) Interaction of organic cations with a newly identified plasma membrane monoamine transporter. Mol Pharmacol 68:1397-1407. (Pubitemid 41539995)
8. Fu W, Franco A, and Trapp S (2009) Methods for estimating the bioconcentration factor of ionizable organic chemicals. Environ Toxicol Chem 28:1372-1379.
9. Gong Y, Zhao Z, McConn DJ, Beaudet B, Tallman M, Speake JD, Ignar DM, and Krise JP (2007) Lysosomes contribute to anomalous pharmacokinetic behavior of melanocortin-4 receptor agonists. Pharm Res 24:1138-1144. (Pubitemid 46798893)
10. Gruenberg J and Stenmark H (2004) The biogenesis of multivesicular endosomes. Nat Rev Mol Cell Biol 5:317-323. (Pubitemid 38480612)
11. Hallberg A, Naeser P, and Andersson A (1990) Effects of long-term chloroquine exposure on the phospholipid metabolism in retina and pigment epithelium of the mouse. Acta Ophthalmol (Copenh) 68:125-130. (Pubitemid 20145443)
12. Hayeshi R, Masimirembwa C, Mukanganyama S, and Ungell AL (2008) Lysosomal trapping of amodiaquine: impact on transport across intestinal epithelia models. Biopharm Drug Dispos 29:324-334.
13. Helip-Wooley A and Thoene JG (2004) Sucrose-induced vacuolation results in increased expression of cholesterol biosynthesis and lysosomal genes. Exp Cell Res 292:89-100. (Pubitemid 38058266)
14. Heuser J (1989) Changes in lysosome shape and distribution correlated with changes in cytoplasmic pH. J Cell Biol 108:855-864.
15. Honegger UE, Quack G, and Wiesmann UN (1993) Evidence for lysosomotropism of memantine in cultured human cells: cellular kinetics and effects of memantine on phospholipid content and composition, membrane fluidity and β-adrenergic transmission. Pharmacol Toxicol 73:202-208. (Pubitemid 23332985)
16. Hostetler KY, Reasor M, and Yazaki PJ (1985) Chloroquine-induced phospholipid fatty liver. Measurement of drug and lipid concentrations in rat liver lysosomes. J Biol Chem 260:215-219. (Pubitemid 15165306)
17. Hostetler KY and Richman DD (1982) Studies on the mechanism of phospholipid storage induced by amantadine and chloroquine in Madin Darby canine kidney cells. Biochem Pharmacol 31:3795-3799. (Pubitemid 13218453)
18. Karbach U, Kricke J, Meyer-Wentrup F, Gorboulev V, Volk C, Loffing-Cueni D, Kaissling B, Bachmann S, and Koepsell H (2000) Localization of organic cation transporters OCT1 and OCT2 in rat kidney. Am J Physiol Renal Physiol 279: F679-F687.
19. Krishna S and White NJ (1996) Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin Pharmacokinet 30:263-299.
20. Kuroda Y and Saito M (2010) Prediction of phospholipidosis-inducing potential of drugs by in vitro biochemical and physicochemical assays followed by multivariate analysis. Toxicol In Vitro 24:661-668.
21. Marceau F, Bawolak MT, Bouthillier J, and Morissette G (2009) Vacuolar ATPase-mediated cellular concentration and retention of quinacrine: a model for the distribution of lipophilic cationic drugs to autophagic vacuoles. Drug Metab Dispos 37:2271-2274.
22. Morissette G, Ammoury A, Rusu D, Marguery MC, Lodge R, Poubelle PE, and Marceau F (2009) Intracellular sequestration of amiodarone: role of vacuolar ATPase and macroautophagic transition of the resulting vacuolar cytopathology. Br J Pharmacol 157:1531-1540.
23. Müller-Höcker J, Schmid H, Weiss M, Dendorfer U, and Braun GS (2003) Chloroquine-induced phospholipidosis of the kidney mimicking Fabry's disease: case report and review of the literature. Hum Pathol 34:285-289. (Pubitemid 36356683)
24. Nilsson C, Kågedal K, Johansson U, and Ollinger K (2003) Analysis of cytosolic and lysosomal pH in apoptotic cells by flow cytometry. Methods Cell Sci 25:185-194.
25. Pardridge WM, Yang J, and Diagne A (1998) Chloroquine inhibits HIV-1 replication in human peripheral blood lymphocytes. Immunol Lett 64:45-47. (Pubitemid 29029878)
26. Piper RC and Katzmann DJ (2007) Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol 23:519-547.
27. Polli JW, Wring SA, Humphreys JE, Huang L, Morgan JB, Webster LO, and Serabjit-Singh CS (2001) Rational use of in vitro P-glycoprotein assays in drug discovery. J Pharmacol Exp Ther 299:620-628. (Pubitemid 32979675)
28. Reasor MJ and Kacew S (2001) Drug-induced phospholipidosis: are there functional consequences? Exp Biol Med (Maywood) 226:825-830. (Pubitemid 34053231)
29. Reece M, Prawitt D, Landers J, Kast C, Gros P, Housman D, Zabel BU, and Pelletier J (1998) Functional characterization of ORCTL2 - an organic cation transporter expressed in the renal proximal tubules. FEBS Lett 433:245-250. (Pubitemid 128369971)
30. Rindler MJ, Chuman LM, Shaffer L, and Saier MH Jr (1979) Retention of differentiated properties in an established dog kidney epithelial cell line (MDCK). J Cell Biol 81:635-648. (Pubitemid 9202331)
31. Saftig P and Klumperman J (2009) Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol 10:623-635.
32. Trapp S, Franco A, and Mackay D (2010) Activity-based concept for transport and partitioning of ionizing organics. Environ Sci Technol 44:6123-6129.
33. Trapp S and Horobin RW (2005) A predictive model for the selective accumulation of chemicals in tumor cells. Eur Biophys J 34:959-966. (Pubitemid 41428192)
34. Walker O, Dawodu AH, Adeyokunnu AA, Salako LA, and Alvan G (1983) Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria. Br J Clin Pharmacol 16:701-705. (Pubitemid 14208210)
35. Wilson PD, Firestone RA, and Lenard J (1987) The role of lysosomal enzymes in killing of mammalian cells by the lysosomotropic detergent N-dodecylimidazole. J Cell Biol 104:1223-1229. (Pubitemid 17084481)
36. Xia L, Zhou M, Kalhorn TF, Ho HT, and Wang J (2009) Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity. Am J Physiol Renal Physiol 296:F1307-F1313.
37. Yu JY and Rosania GR (2010) Cell-based multiscale computational modeling of small molecule absorption and retention in the lungs. Pharm Res 27:457-467.
38. Zhang X, Shedden K, and Rosania GR (2006) A cell-based molecular transport simulator for pharmacokinetic prediction and cheminformatic exploration. Mol Pharm 3:704-716. (Pubitemid 46087486)
39. Zhang X, Zheng N, Zou P, Zhu H, Hinestroza JP, and Rosania GR (2010) Cells on pores: a simulation-driven analysis of transcellular small molecule transport. Mol Pharm 7:456-467.
40. Zolk O, Solbach TF, König J, and Fromm MF (2009) Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2). Naunyn Schmiedebergs Arch Pharmacol 379:337-348.